Bavarian Nordic’s MVA-BN vaccine is called Imvanex in Europe but is known as Jynneos in countries such as the US and ...

After missing primary endpoints in relapsing forms of MS, tolebrutinib has proved its efficacy in secondary progressive MS ...

The biotech has secured $65m in a Series A funding round led by Cormorant Asset Management and other investors.

The growth of AI in the healthcare sector is already having real-world impacts and promises a step-change in future care.

Solving adherence issues with prodrugs, examining whether PBMs are to blame for high drugs prices in the US, developing ...